Galcanezumab (Emgality)’s Reviews

U

Tell us how Galcanezumab (Emgality) treated you

Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision. Add your review.

pascalpoe

pascalpoe

@pascalpoe

Anyone with Post-COVID Migraine / Headache should try this class of medications

Chronic Illnesses: Long COVID
Symptoms Treated: Migraine - Improved but only during treatment Hyperacusis - Improved but only during treatment

I started on the recommended dose of Emgality, 240mg loading dose and then 120mg / month thereafter. This did NOT work. My migraines would improve significantly for about 7-10 days, and then they would come back worse than before for the rest of the month. It seemed to me that the dose wasn’t high enough and was wearing off too quickly. My neurologist agreed to allow me to take 240mg every two weeks, 4 times the approved dose. Since then it’s been amazing. Almost no migraines since we switched to this protocol. This is uncharted territory, as post-COVID migraines are not understood and there are no clinical trials testing these mAbs on post-COVID patients. But at least for my case, I needed a way higher dose than other people with migraines do.

Details

  • Dosage 480mg / month
  • Source Neurologist
  • Last used <6mo ago
  • Times used 11-50 times
  • Insurance covered Unsure
  • Cost per month $1000+

Share with friends:

Think this information is wrong?